The impact of thrombosis on probabilities of death and disease progression in polycythemia vera: a multistate transition analysis of 1,545 patients

Abstract We applied a parametric Markov five-state model, on a well-characterized international cohort of 1,545 patients with polycythemia vera (PV; median age 61 years; females 51%), in order to examine the impact of incident thrombosis on the trajectory of death or disease progression. At a median...

Full description

Bibliographic Details
Main Authors: Tiziano Barbui, Alessandra Carobbio, Juergen Thiele, Naseema Gangat, Elisa Rumi, Alessandro Rambaldi, Alessandro M. Vannucchi, Ayalew Tefferi, IWG-MRT group
Format: Article
Language:English
Published: Nature Publishing Group 2023-12-01
Series:Blood Cancer Journal
Online Access:https://doi.org/10.1038/s41408-023-00960-1
_version_ 1797388542378246144
author Tiziano Barbui
Alessandra Carobbio
Juergen Thiele
Naseema Gangat
Elisa Rumi
Alessandro Rambaldi
Alessandro M. Vannucchi
Ayalew Tefferi
IWG-MRT group
author_facet Tiziano Barbui
Alessandra Carobbio
Juergen Thiele
Naseema Gangat
Elisa Rumi
Alessandro Rambaldi
Alessandro M. Vannucchi
Ayalew Tefferi
IWG-MRT group
author_sort Tiziano Barbui
collection DOAJ
description Abstract We applied a parametric Markov five-state model, on a well-characterized international cohort of 1,545 patients with polycythemia vera (PV; median age 61 years; females 51%), in order to examine the impact of incident thrombosis on the trajectory of death or disease progression. At a median follow-up of 6.9 years, 347 (23%) deaths, 50 (3%) blast phase (BP), and 138 (9%) fibrotic (post-PV MF) transformations were recorded. Incident thrombosis occurred at a rate of 2.62% pt/yr (arterial 1.59% and venous 1.05%). The probability of death, in the first 10 years, for 280 (18%) patients who developed thrombosis during follow-up was 40%, which was two-fold higher than that seen in the absence of thrombosis or any other transition state (20%; p < 0.01); the adverse impact from thrombosis was more apparent for arterial (HR 1.74; p < 0.01) vs venous thrombosis (p=NS) and was independent of other fixed (i.e., age, prior venous thrombosis, leukocytosis) or time-dependent (i.e., progression to BP or MF) risk variables. The transition probability to post-PV MF increased over time, in a linear fashion, with a rate of 5% capped at 5 and 10 years, in patients with or without incident thrombosis, respectively. The impact of thrombosis on transition probability to death or post-PV MF tapered off beyond 10 years and appeared to reverse direction of impact on MF evolution at the 12-year time point. These observations suggest thrombosis in PV to be a marker of aggressive disease biology or a disease-associated inflammatory state that is consequential to both thrombosis and disease progression.
first_indexed 2024-03-08T22:41:20Z
format Article
id doaj.art-6474a721d23f450c80a8f7af9c2595d4
institution Directory Open Access Journal
issn 2044-5385
language English
last_indexed 2024-03-08T22:41:20Z
publishDate 2023-12-01
publisher Nature Publishing Group
record_format Article
series Blood Cancer Journal
spelling doaj.art-6474a721d23f450c80a8f7af9c2595d42023-12-17T12:07:33ZengNature Publishing GroupBlood Cancer Journal2044-53852023-12-011311510.1038/s41408-023-00960-1The impact of thrombosis on probabilities of death and disease progression in polycythemia vera: a multistate transition analysis of 1,545 patientsTiziano Barbui0Alessandra Carobbio1Juergen Thiele2Naseema Gangat3Elisa Rumi4Alessandro Rambaldi5Alessandro M. Vannucchi6Ayalew Tefferi7IWG-MRT groupFROM Research Foundation, Papa Giovanni XXIII HospitalFROM Research Foundation, Papa Giovanni XXIII HospitalInstitute of Pathology, University of CologneHematology Division, Mayo ClinicDepartment of Molecular Medicine, University of PaviaHematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIIICenter Research and Innovation of Myeloproliferative Neoplasms (CRIMM), Department of Experimental and Clinical Medicine, Azienda Ospedaliera Universitaria Careggi, University of FlorenceHematology Division, Mayo ClinicAbstract We applied a parametric Markov five-state model, on a well-characterized international cohort of 1,545 patients with polycythemia vera (PV; median age 61 years; females 51%), in order to examine the impact of incident thrombosis on the trajectory of death or disease progression. At a median follow-up of 6.9 years, 347 (23%) deaths, 50 (3%) blast phase (BP), and 138 (9%) fibrotic (post-PV MF) transformations were recorded. Incident thrombosis occurred at a rate of 2.62% pt/yr (arterial 1.59% and venous 1.05%). The probability of death, in the first 10 years, for 280 (18%) patients who developed thrombosis during follow-up was 40%, which was two-fold higher than that seen in the absence of thrombosis or any other transition state (20%; p < 0.01); the adverse impact from thrombosis was more apparent for arterial (HR 1.74; p < 0.01) vs venous thrombosis (p=NS) and was independent of other fixed (i.e., age, prior venous thrombosis, leukocytosis) or time-dependent (i.e., progression to BP or MF) risk variables. The transition probability to post-PV MF increased over time, in a linear fashion, with a rate of 5% capped at 5 and 10 years, in patients with or without incident thrombosis, respectively. The impact of thrombosis on transition probability to death or post-PV MF tapered off beyond 10 years and appeared to reverse direction of impact on MF evolution at the 12-year time point. These observations suggest thrombosis in PV to be a marker of aggressive disease biology or a disease-associated inflammatory state that is consequential to both thrombosis and disease progression.https://doi.org/10.1038/s41408-023-00960-1
spellingShingle Tiziano Barbui
Alessandra Carobbio
Juergen Thiele
Naseema Gangat
Elisa Rumi
Alessandro Rambaldi
Alessandro M. Vannucchi
Ayalew Tefferi
IWG-MRT group
The impact of thrombosis on probabilities of death and disease progression in polycythemia vera: a multistate transition analysis of 1,545 patients
Blood Cancer Journal
title The impact of thrombosis on probabilities of death and disease progression in polycythemia vera: a multistate transition analysis of 1,545 patients
title_full The impact of thrombosis on probabilities of death and disease progression in polycythemia vera: a multistate transition analysis of 1,545 patients
title_fullStr The impact of thrombosis on probabilities of death and disease progression in polycythemia vera: a multistate transition analysis of 1,545 patients
title_full_unstemmed The impact of thrombosis on probabilities of death and disease progression in polycythemia vera: a multistate transition analysis of 1,545 patients
title_short The impact of thrombosis on probabilities of death and disease progression in polycythemia vera: a multistate transition analysis of 1,545 patients
title_sort impact of thrombosis on probabilities of death and disease progression in polycythemia vera a multistate transition analysis of 1 545 patients
url https://doi.org/10.1038/s41408-023-00960-1
work_keys_str_mv AT tizianobarbui theimpactofthrombosisonprobabilitiesofdeathanddiseaseprogressioninpolycythemiaveraamultistatetransitionanalysisof1545patients
AT alessandracarobbio theimpactofthrombosisonprobabilitiesofdeathanddiseaseprogressioninpolycythemiaveraamultistatetransitionanalysisof1545patients
AT juergenthiele theimpactofthrombosisonprobabilitiesofdeathanddiseaseprogressioninpolycythemiaveraamultistatetransitionanalysisof1545patients
AT naseemagangat theimpactofthrombosisonprobabilitiesofdeathanddiseaseprogressioninpolycythemiaveraamultistatetransitionanalysisof1545patients
AT elisarumi theimpactofthrombosisonprobabilitiesofdeathanddiseaseprogressioninpolycythemiaveraamultistatetransitionanalysisof1545patients
AT alessandrorambaldi theimpactofthrombosisonprobabilitiesofdeathanddiseaseprogressioninpolycythemiaveraamultistatetransitionanalysisof1545patients
AT alessandromvannucchi theimpactofthrombosisonprobabilitiesofdeathanddiseaseprogressioninpolycythemiaveraamultistatetransitionanalysisof1545patients
AT ayalewtefferi theimpactofthrombosisonprobabilitiesofdeathanddiseaseprogressioninpolycythemiaveraamultistatetransitionanalysisof1545patients
AT iwgmrtgroup theimpactofthrombosisonprobabilitiesofdeathanddiseaseprogressioninpolycythemiaveraamultistatetransitionanalysisof1545patients
AT tizianobarbui impactofthrombosisonprobabilitiesofdeathanddiseaseprogressioninpolycythemiaveraamultistatetransitionanalysisof1545patients
AT alessandracarobbio impactofthrombosisonprobabilitiesofdeathanddiseaseprogressioninpolycythemiaveraamultistatetransitionanalysisof1545patients
AT juergenthiele impactofthrombosisonprobabilitiesofdeathanddiseaseprogressioninpolycythemiaveraamultistatetransitionanalysisof1545patients
AT naseemagangat impactofthrombosisonprobabilitiesofdeathanddiseaseprogressioninpolycythemiaveraamultistatetransitionanalysisof1545patients
AT elisarumi impactofthrombosisonprobabilitiesofdeathanddiseaseprogressioninpolycythemiaveraamultistatetransitionanalysisof1545patients
AT alessandrorambaldi impactofthrombosisonprobabilitiesofdeathanddiseaseprogressioninpolycythemiaveraamultistatetransitionanalysisof1545patients
AT alessandromvannucchi impactofthrombosisonprobabilitiesofdeathanddiseaseprogressioninpolycythemiaveraamultistatetransitionanalysisof1545patients
AT ayalewtefferi impactofthrombosisonprobabilitiesofdeathanddiseaseprogressioninpolycythemiaveraamultistatetransitionanalysisof1545patients
AT iwgmrtgroup impactofthrombosisonprobabilitiesofdeathanddiseaseprogressioninpolycythemiaveraamultistatetransitionanalysisof1545patients